Home Compare AFX.DE vs DRS
Stock Comparison · Valuation-led comparison

Carl Zeiss Meditec vs Leonardo DRS: Which Stock Looks Stronger in 2026?

Carl Zeiss Meditec leads structurally, with valuation as the clearest single gap between the two profiles. Leonardo DRS still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, Leonardo DRS carries the stronger setup — intact trend against Carl Zeiss Meditec's broken trend. That leaves a split case: the structural lead stays with Carl Zeiss Meditec, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Most of the separation is still concentrated in valuation.

Trajectory Similarity
0.71
Similar
Peer-set rank: #6
within Carl Zeiss Meditec AG's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

The strongest overlap appears in revenue stability and operating margin level.

Similarity drivers
revenue stabilityoperating margin level
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AFX.DE
Carl Zeiss Meditec AG
47
Peer-Score
Signal qualityHigh
vs
DRS
Leonardo DRS, Inc.
41
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: AFX.DE vs DRS Profitability 35 42 Stability 24 44 Valuation 86 50 Growth 28 21 AFX.DE DRS
Gap Ranking
#1 Valuation +36
#2 Stability +20
#3 Growth +7
#4 Profitability +7
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AFX.DE and DRS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AFX.DEDRS Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Leonardo DRS, Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both rank well on valuation, but Carl Zeiss Meditec AG still holds a clear edge.
Stability
Leonardo DRS, Inc. sits higher in the group on stability, adding to the overall structural advantage.
Valuation — Dominant Gap
AFX.DE
86
DRS
50
Gap+36in favour of AFX.DE

The multiple-based pricing edge comes from a forward P/E that is 19.1 turns lower.

What keeps the gap from being one-sided

A meaningful counterforce remains in stability, which keeps the comparison from looking completely one-sided.

What this means for the comparison

The main read on valuation is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the AFX.DE vs DRS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how AFX.DE and DRS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.